All In Biotech

Drug Trial Radar · NCT06842355

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

A Multicenter, Phase 2, Dose-Escalation/Dose-Expansion Study of TYRA-300 in Children With Achondroplasia With Open Growth Plates: BEACH301

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

92

Planned (sponsor's estimate)

Start

Mar 4, 2025

Primary completion

Jan 2030

Study completion Jun 2030

Sponsor

Lead sponsor
Tyra Biosciences, IncIndustry
Sponsor type
Industry
First posted
Feb 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 years, up to 10 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, and identify potentially effective dose(s) of TYRA-300 in children with achondroplasia with open growth plates.

Conditions

  • Achondroplasia

Interventions

  • TYRA-300 0.125 mg/kgDrug

    Initial dose level of TYRA-300 per protocol, subsequent dose level escalations will occur based on criteria outlined in the protocol.

  • TYRA-300 0.25 mg/kgDrug

    Subsequent dose level escalations will occur based on criteria outlined in the protocol.

  • TYRA-300 0.375 mg/kgDrug

    Subsequent dose level escalations will occur based on criteria outlined in the protocol.

  • TYRA-300 0.50 mg/kgDrug

    Subsequent dose level escalations will occur based on criteria outlined in the protocol.

  • TYRA-300 0.625 mg/kgDrug

    Subsequent dose level escalations may occur based on criteria outlined in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment-related adverse events as assessed by CTCAE v5.0Time frame: Up to 12 months
  2. Change from baseline in annualized growth velocity (Cohort 1)Time frame: 12 months

Locations

26 sites in 8 countries. Site status is shown where the registry gives one.

  • Lundquist Institute for Biomedical Innovation

    Torrance, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Nemours Alfred I duPont Hospital for Children

    Wilmington, Delaware · Recruiting

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland · Recruiting

  • Uncommon Cures

    Chevy Chase, Maryland · Recruiting

  • University of Missouri

    Columbia, Missouri · Recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • Duke University Hospital

    Durham, North Carolina · Recruiting

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Recruiting

  • Children's Medical Center, Dallas

    Dallas, Texas · Recruiting

  • University of Texas Health Science Center Medical School at Houston

    Houston, Texas · Recruiting

  • University of Wisconsin-Madison

    Madison, Wisconsin · Recruiting

  • The Children's Hospital at Westmead

    Westmead, New South Wales, Australia · Recruiting

  • Royal Children's Hospital

    Parkville, Victoria, Australia · Recruiting

  • Women's and Children's Health Research Institute, University of Alberta

    Edmonton, Alberta, Canada · Recruiting

  • Children's Hospital of Eastern Ontario

    Ottawa, Ontario, Canada · Recruiting

  • The Hospital for Sick Children

    Toronto, Ontario, Canada · Recruiting

  • Imagine Institute

    Paris, France · Recruiting

  • CHU de Montpellier Parent

    Montpellier, Herault, France · Recruiting

  • UMC Utrecht

    Utrecht, Netherlands · Recruiting

  • Unidad de Cirugía Artroscópica (MIKS Hospital)

    Vitoria-Gasteiz, Alava, Spain · Recruiting

  • Hospital Univeristario La Paz

    Madrid, Madrid, Spain · Recruiting

  • Astrid Lindgren Children's Hospital (Karolinska University Hospital)

    Stockholm, Sweden · Recruiting

  • Guy's & St Thomas NHS Foundation Trust 2

    London, Greater London, United Kingdom · Recruiting

  • Great Ormond Street Hospital

    London, Greater London, United Kingdom · Recruiting

  • Sheffield Children's Hospital

    Sheffield, South Yorkshire, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.